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In western countries, aging is often accompanied by obesity and age-related obesity is characterized by vascular dysfunction and a
low-grade inﬂammatory proﬁle. Exercise is a nonpharmacological strategy able to decrease the development and incidence of risk
factors for several health-threatening diseases. Nonetheless, its long-term eﬀect on vascular function and inﬂammation in age-
related obesity is still unclear. The aim of this study was to investigate the eﬀect of regular, supervised exercise on inﬂammatory
proﬁle and vascular function in age-related obesity. We also hypothesized that vascular function and inﬂammatory proﬁle
would have been correlated in overweight and obese individuals. Thirty normal weight (NW; 70± 5 years, 23.9± 2.6 BMI) and
forty overweight and obese elderly (OW&OB; 69± 5 years, 30.1± 2.3 BMI) regularly taking part in a structured, supervised
exercise program were enrolled in the study and evaluated for vascular function (ﬂow-mediated dilation; FMD) and
inﬂammatory proﬁle (plasma CRP, IL-1β, IL-1ra, IL-6, IL-8, IL-10, TNF-α, and MCP-1). Although no diﬀerences between
groups were found concerning performance and the weekly amount of physical activity, the OW&OB group compared with the
NW group demonstrated higher systolic and diastolic blood pressure (+10%, p = 0 001; +9%, p = 0 005, respectively); lower
FMD% (−36%, p < 0 001) and FMD/shear rate (−40%, p = 0 001); and higher levels of CRP (+33%, p = 0 005), IL-6 (+36%, p =
0 048), MCP-1 (+17%, p = 0 004), and TNF-α (+16%, p = 0 031). No correlations between vascular function and inﬂammation
were found in OW&OB or NW. Although exercising regularly, overweight and obese elderly exhibited poorer vascular function
and higher proinﬂammatory markers compared with the leaner group. These results support the idea that exercise alone cannot
counteract the negative eﬀect of adiposity on vascular function and inﬂammatory proﬁle in elderly individuals and these two
processes are not necessarily related.
1. Introduction
Aging, an inevitable and unstoppable process, is a well-
documented risk factor for cardiovascular and atheroscle-
rotic disease and it is associated with a progressive decline
in endothelium-dependent vasodilation in both resistance
and conduit arteries [1, 2]. These alterations are primarily
related to a worsening of mitochondrial function, increased
inﬂammatory proﬁle, augmented free radical production,
and a gradual loss of antioxidant capacity [2, 3]. Altogether,
these mechanisms lead to an impairment of nitric oxide
(NO) bioavailability [1–3], with reduced endothelium-
dependent vasodilation, serving as a risk factor for diabetes,
hypertension, dyslipidemia, and several forms of cancer [4].
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Obesity is another condition known to be characterized by
vascular dysfunction and, diﬀerently from aging, is a revers-
ible state. Indeed, increased body fat is associated with
increased inﬂammatory proﬁle, as well as with increased
reactive oxygen species (ROS) production and impaired
NO-mediated endothelium-dependent vasodilation [5, 6].
Older adults represent the faster growing population in
Europe and all over the world, and the prevalence of obesity
among this population is about 20–30% [7]. Indeed, aging is
also characterized by increased fat mass and loss of fat-free
mass, with a concomitant increase of overall adiposity stored
primarily as triglycerides in subcutaneous and visceral adi-
pose tissue, as well as in nonadipose tissues such as skeletal
muscles and liver [8]. Consequently, the aging process itself
and the age-dependent accumulation of adipose tissue
contribute both to the onset and development of NO-
mediated vascular dysfunction with a detrimental eﬀect on
the incidence of cardiometabolic diseases such as hyperten-
sion, dyslipidemia, and diabetes, as well as the development
of cancer [5, 9–11]. However, evidence showing the relation
between higher inﬂammatory proﬁle and lower vascular
function in obese elderly individuals is lacking and speciﬁc
studies are needed.
Recent evidence has shown that physical activity can
improve the inﬂammatory proﬁle and endothelium-
dependent vasodilation in healthy individuals as well as in
individuals with endothelial dysfunction associated with
chronic conditions [1]. Physical training has beneﬁcial eﬀects
on several cardiovascular risk factors such as dyslipidemia,
hypertension, and diabetes, and can serve as an intervention
to lower the risk of developing several health-threatening
conditions such as cardiovascular chronic disease and cancer
[2]. Studies on healthy and active aging have shown that in
contrast to their sedentary counterparts, older men who per-
formed regular aerobic exercise have largely preserved vascu-
lar function, lower low-grade inﬂammation, and reduced risk
factors for several invalidating diseases [3, 4, 6, 12]. However,
a recent study aimed at evaluating the eﬀect of long-term
physical activity intervention on vascular health and inﬂam-
matory biomarkers in the elderly did not provide further
evidence for the beneﬁcial eﬀect of regular exercise in older
adults [13]. Recently, some publications have emerged
claiming that physical activity counteracts obesity as a risk
factor [5, 10, 14]. Nevertheless, other studies have shown that
regular physical activity protects against incident cardiovas-
cular disease, but it does not eliminate the harmful eﬀect of
overweight and obesity [5, 11, 15–17]. Moreover, it is impor-
tant to highlight that no studies have aimed at investigating
the exercise-induced eﬀects on vascular function and inﬂam-
matory proﬁle in age-related obesity.
Consequently, due to contrasting results about the eﬀect
of regular exercise on inﬂammatory proﬁle and vascular
function in aging and obesity, and the lack of evidence about
the eﬀect of exercise on aging-induced obesity, the aim of this
study was to investigate the eﬀect of regular, supervised
exercise on inﬂammatory proﬁle and vascular function in
nonobese and obese elderly who habitually take part in a
supervised exercise program. The aim of this study was to
investigate the eﬀects of regular, supervised exercise on
vascular function and inﬂammatory proﬁle in obese and
nonobese older individuals.
2. Methods
2.1. Subjects. The study population included 70 physically
active older adults (30 females, 40 males, mean age 70± 5
years, 30 nonobese, 15 overweight, and 25 obese) (Table 1)
who habitually took part in a structured, supervised exercise
program. Subjects were included in the study in the absence
of smoking history, atherosclerotic vascular disease, heart
failure, and liver, renal, or inﬂammatory disease, and if
they did not experience great body mass index (BMI)
variation in the last 5 years (≤0.7 kg ∙ (m2)−1). None of
the subjects was subjected to a caloric restriction diet at
the time of the study. Subjects were informed about testing
procedures, possible risks, and discomfort that might
ensue and gave their written informed consent to partici-
pate in accordance with the Declaration of Helsinki, as
part of a protocol approved by the Institutional Review
Board of the Azienda Ospedaliera Universitaria Integrata
of Verona, Italy (protocol # 788CESC).
One day preceding the tests, the subjects were prohibited
from training and their normal diet was maintained. A
Table 1: Subjects characteristics and between groups comparison.
NW (n = 30) OW&OB (n = 40) p
Age (years) 70.3± 4.7 69.4± 5.4 ns
Female/male (n) 16/14 23/17 ns
BMI (kg ∙ (m2)−1) 23.9± 2.6 30.1± 2.3 p < 0 001
Sys (mmHg) 133.1± 14.7 147.5± 16.2 p = 0 001
Dia (mmHg) 76.7± 7.6 83.9± 10.4 p = 0 005
Medications
Statin—n (%) 7 (23) 10 (25) ns
Diuretics—n (%) 5 (17) 7 (18) ns
Antiacid—n (%) 5 (17) 6 (15) ns
Physical activity
Years 5± 1 5± 2 ns
Min/week 209.4± 82.5 221.7± 71.3 ns
Days/week 3± 1 3± 1 ns
6MWT (m) 610.1± 68.5 610.0± 83.7 ns
Inﬂammatory proﬁle
IL-10 (ng/mL) 18.9± 22.6 16.6± 17.2 ns
IL-1ra (ng/mL) 61.9± 33.6 52.7± 24.1 ns
IL-1β (ng/mL) 9.1± 7.2 7.8± 5.1 ns
IL-8 (ng/mL) 5.9± 4.4 7.1± 4.1 ns
∗Plus-minus values are means ± standard deviation (SD). One-way
ANOVA was used to identify between-group diﬀerences for parametric
variables, followed by the Holm-Sidak test. The Kruskal-Wallis one-way
analysis of variance on ranks was used for nonparametric variables,
followed by the Tukey test. Note: NW: normal weight; OW&OB:
overweight and obese; BMI: body mass index, activity (min/week); Sys:
systolic blood pressure; Dia: diastolic blood pressure; FMD: ﬂow-mediated
dilation; 6MWT: 6-minute walking test; CRP: C-reactive protein; IL:
interleukin; MCP-1: monocyte chemoattractant protein-1; TNF-α: tumor
necrosis factor-α; p = p value.
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vascular test and blood sampling were carried out on the
same day. Room temperature was 22–24°C, and relative
humidity was 50%. All the ultrasound studies were
performed by a single experienced vascular sonographer
who was unaware of the clinical and laboratory character-
istics of the subjects. Height and weight were recorded by
means of a scale and stadiometer (Seca, Hamburg,
Germany), and body mass index (BMI) was calculated as
weight (kg)/height (m)2.
The study was conducted in September 2017, right
before the beginning of the annual exercise program (which
starts in September and ends in July, having about a 4-week
break in summer). The data were collected at the beginning
of a new year of the exercise program from subjects who
have been taking part in this program for about 5 years, 3
days a week, allowing us to consider these people as active
and trained even after a break of a few weeks. Also, a battery
of performance and functional tests including a 6-minute
walking test (6MWT) was performed at the beginning of
the exercise program in order to set the exercise goals.
Brieﬂy, 6MWT measures the maximum distance that a
person can walk over 6min and it is commonly used as an
assessment of exercise capacity. The distance (m) covered
in 6min was recorded [18].
2.2. Blood Samples and Analysis. Venous blood samples were
drawn from an antecubital vein and collected into EDTA
tubes for analysis of inﬂammatory proﬁles. The samples were
centrifuged for 10 minutes at +4°C with 2500×g. Plasma was
kept at −80°C until analyzed for interelukine-1ra (IL1-ra;
Chi, 4.67%; CV, 0.034%; DC = 0 10, 18011 00 ), interleu-
kin-1β (IL-1β; Chi, 6.86%; CV, 0.65%; DC = 0 057,
23660 71 ), interleukin-6 (IL-6; Chi, 7.70%; CV, 0.36%; D
C = 0 39, 47602 24 ), interleukin-8 (IL-8; Chi, 2.15%;
CV,0.21%; DC = 0 18, 41913 46 ), interleukin-10 (IL-10;
Chi, 7.29%; CV, 0.66%; DC = 0 36, 10173 63 ), tumor
necrosis factor-α (TNF-α; Chi, 7.02%; CV, 0.77%; DC =
0 28, 15643 48 ), and monocyte chemoattractant protein-1
(MCP-1; Chi, 4.73%; CV, 0.68%; DC = 0 43, 21239 64 ),
which were determined by means of the commercially
available MILLIPLEX multianalyte panel HCYTOMAG-
60K-07 (Merck Millipore, Darmstadt, Germany) following
the manufacturer’s recommendation. C-reactive protein
(CRP) was measured using an ELISA commercial kit, fol-
lowing the manufacturer’s recommendation (Diagnostics
Biochem Canada Inc. (DBC), London, Canada). We
included both pro- and anti-inﬂammatory markers related
with exercise as well as related with the development of
risk factors for several health-threatening diseases.
2.3. Flow-Mediated Dilation (FMD) Test. The FMD test has
been proposed to represent a functional bioassay for
endothelium-derived NO bioavailability and vascular func-
tion in humans [19]. The FMD test was performed in a quiet
room with participants in abstinence from alcohol, antioxi-
dants (i.e., orange juice and beetroot juice), and caﬀeine for
at least 12 h [20]. High-resolution ultrasound was used to
image the brachial artery at rest and after 5min of ischemia.
All the FMD tests were performed with the participant in the
supine position, with the right arm extended at an angle of
~90° from the torso. The brachial artery was imaged using
the high-resolution ultrasound system LOGIQ-7 ultrasound
Doppler system (General Electric Medical Systems, Milwau-
kee, WI, USA). The ultrasound Doppler system was
equipped with a 12–14MHz linear array transducer. The
brachial artery was imaged 5–10 cm above the antecubital
fossa in the longitudinal plan, and the diameter was
determined at 90° angle along the central axis of the scanned
area. When an optimal image was acquired, the position was
maintained for the whole test and all scans were stored for
later analysis. After baseline brachial artery imaging, a blood
pressure cuﬀ was placed around the forearm and inﬂated to
250mmHg for 5min. Brachial artery images and blood
velocity were obtained continuously 30 s before and 2min
after cuﬀ release [19]. The brachial artery images were
analyzed by a blinded investigator by means of FloWave.US
[21]. Arterial diameter was measured as the distance (mm)
between the intima-lumen interfaces for the anterior and
posteriors walls. Utilizing arterial diameter and the blood
velocity, blood ﬂow (BF) was calculated as follows:
BF  ml/min = blood velocity ⋅Π ⋅ vessel diameter2
2
⋅ 60
1
The calculation of FMD as a percentage change uses the
peak diameter in response to reactive hyperemia in relation
to the baseline diameter and was calculated as follows:
FMD % = peak diameter − baseline diameterbaseline diameter , 2
and when multiplied by 100, FMD is expressed as a percent-
age of change in the vessel caliber [19].
Postcuﬀ release shear rate was calculated using the fol-
lowing equation: shear rate s−1 = 8Vmean/vessel diameter.
Cumulative shear rate (s−1∙s) and the reactive postcuﬀ release
(total blood ﬂow over 2min) were integrated using the trap-
ezoidal rule and calculated as
〠 yi x i+1 − xi +
1
2 y i+1 − yi x i+1 − xi 3
Consequently FMDwas normalized for shear rate (FMD/
shear rate) [19].
2.4. Supervised Exercise Training. Individuals included in the
study habitually exercised at the “Silver Fitness” program
going on at the Department of Neurosciences, Biomedicine
and Movement Sciences, Section of Movement Sciences, at
the University of Verona, Italy. All individuals exercised at
least twice a week for 90 minutes combining moderate inten-
sity endurance and resistance training. Sessions usually
started with 15 minutes of warm up, which included active
joint mobilization and walking on a treadmill or cycling at
a preferred speed. Then, individuals performed two 15-
minute endurance exercises (either on a cycle ergometer,
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treadmill, or arm-cranking ergometer) at 70% of the maximal
heart rate (calculated using the Karvonen formula: 220− age
in years). Subsequently, individuals performed 3 sets of 8 to
12 reps of resistance exercises at 60–75% of 1 repetition max-
imum (1RM). 1RM was determined by means of the Brzycki
method [22] for all the isotonic ergometers included in the
training (i.e., chest press, lat machine, leg press, and others,
Technogym, Gambettola, Italy) every year at the beginning
of the training program and every 4 months over the year
to adjust the work load for the improvements achieved. Exer-
cise sessions ended with stretching exercises for all the mus-
cles involved in the training. All training sessions were
supervised by kinesiologists, with a ratio of 1 : 6 (1 kinesiolo-
gist supervising 6 participants).
2.5. Statistical Analysis. Data are expressed as mean± SD and
minimum-maximum range. One-way ANOVA was used to
identify between-group diﬀerences for parametric variables
(age, systolic blood pressure, FMD%, and shear rate),
followed by the Holm-Sidak test. The Kruskal-Wallis one-
way analysis of variance on ranks was used for nonparamet-
ric variables (quantity of physical activity, BMI, diastolic
blood pressure, FMD/shear rate, 6-MWT, CRP, IL-1ra, IL-
1β, IL-6, IL-8, IL-10, MCP-1, and TNF-α), followed by the
Tukey post hoc test. The Pearson product moment correla-
tion was used to identify correlations between vascular func-
tion variables and inﬂammation markers. All statistical
analyses were performed with SigmaPlot Windows Version
12.0 (Systat Software, Chicago, IL).
3. Results
3.1. Characteristics of the Participants. Individuals included
in this study were 70± 5 years old and included 39 females
and 31 males. The most common medications taken by the
participants were statins, taken by 24% of the participants;
diuretics, taken by 17% of the participants; and antiacids,
taken by 16% of the participants. Interestingly, although a
history of high blood pressure was not reported by the partic-
ipants, on average both of the groups exhibited high values of
systolic blood pressure (see Table 1). We also investigated the
sex-speciﬁc diﬀerences in the variables we assessed; however,
diﬀerences between males and females were not found.
Referring to the quantity of physical activity, on average all
individuals included in the study have been taking part in
the exercise program for 5± 1 years and were involved 3
± 1 days/week, for a total amount of 270± 60minutes per
week (see Table 1).
3.2. Lean vs. Overweight and Obese Subjects. NW and
OW&OB did not diﬀer for age, number of males and
females in the groups, medicine intake, years practicing
physical activity, weekly amount of physical activity, and
performance measured as 6-MWT (see Table 1). As
expected, the OW&OB group had a 20.6% higher BMI
compared with the NW group (p < 0 001). Regarding the
vascular function, no diﬀerence between groups was found
in the hyperemic response during the FMD test (see
Figure 1) or in the shear rate (see Figure 2(b)). Neverthe-
less, the OW&OB group exhibited a 9.8% higher systolic
blood pressure (p = 0 001) and an 8.6% higher diastolic
blood pressure (p = 0 005), as well as a 35.5% lower
FMD% (see Figure 2(a), p < 0 001) and a 39.7% lower
FMD/shear rate (see Figure 2(c), p = 0 001) than the NW
group. Concerning the inﬂammatory proﬁle, no signiﬁcant
diﬀerences between groups were found for many cytokines,
such as IL-10, IL-1ra, IL-1β, and IL-8. However, the
OW&OB group exhibited higher values of proinﬂammatory
cytokines, such as a 32.9% higher CRP level (see Figure 3(a),
p = 0 005), a 35.5% higher IL-6 level (see Figure 3(b), p =
0 048), a 15.8% higher TNF-α level (see Figure 3(c), p =
0 0031), and a 16.7% higher MCP-1 level (see Figure 3(d),
p = 0 004) compared with the NW group. When investigat-
ing the correlation between vascular function and inﬂamma-
tory proﬁle, no signiﬁcant results were found in NW or
OW&OB (see Table 2).
4. Discussion
Although several studies have investigated the eﬀect of
exercise on age-related and obesity-related morbidities, no
studies have aimed at investigating the exercise-induced
eﬀects on vascular function and inﬂammatory proﬁle in
age-related obesity without inclusion of caloric restriction.
Numerous studies highlighted the fact that during the aging
process there is an increase in overall adiposity and a decre-
ment in fat-free mass contributing to lower vascular function
and an increase in the low-grade inﬂammatory proﬁle.
Numerous reviews about vascular function and inﬂammatory
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Figure 1: Reactive hyperemic response during the FMD test.
Increase in brachial artery blood ﬂow in the normal weight (NW)
group and overweight and obese (OW&OB) group during the 2
minutes following a 5-minute supersystolic occlusion during the
FMD test.
4 Journal of Immunology Research
proﬁle in obese older adults also recommend exercise as an
eﬀective intervention [7, 8, 10]. However, no studies have
investigated the eﬀect of exercise without caloric restriction
on vascular function and inﬂammatory proﬁle in older obese
adults. In the present study, we measured endothelial func-
tion and inﬂammatory proﬁle in habitually exercising obese
and nonobese older adults who have been taking part in a
structured, supervised exercise program for several years
without caloric restriction. In accordance with our hypothe-
sis, the eﬀects of elevated adiposity on endothelial function
and inﬂammatory proﬁle were not blunted in exercising
overweight and obese individuals, demonstrating that exer-
cise alone cannot serve as a fully successful strategy. More-
over, even though obese individuals exhibited poorer
vascular function and higher proinﬂammatory values, these
two phenomena do not seem to be correlated.
4.1. Evidence about the Eﬃcacy of Exercise on Vascular
Functions in Age-Related Obesity. Although several studies
have already investigated the eﬀects of exercise intervention
on vascular functions in aging and obesity supporting a
positive exercise-induced adaptation, the majority of the
studies investigated short-term exercise programs adminis-
tered to previous sedentary obese subjects [4, 6]. Vinet
et al. [6] investigated the eﬀect of short-term low-intensity
exercise training in middle-age obese men. Ten individuals
were recruited and tested for brachial FMD before and after
8 weeks of an individualized low-intensity program, without
any dietary intervention. Compared with normal weight con-
trols, obese individuals exhibited poorer FMD; however,
exercise training ameliorated FMD values in the obese group.
The authors concluded that a short-term low-intensity exer-
cise training improves endothelium-dependent vasodilation
in sedentary middle-age obese men [6]. Another study by
Dow et al. [4] showed that regular aerobic exercise reduces
ET-1-mediated vasoconstrictor tone in overweight and obese
middle-aged adults, and they concluded that these mecha-
nisms may be very important in the exercise-induced
improvement in endothelium-dependent vasodilator func-
tion in this population.
Our results are not in agreement with the mentioned
studies. Indeed, the obese elderly individuals included in
our study, who were not undertaking a caloric restriction
diet, showed a signiﬁcantly decreased vascular function
compared with age-matched counterparts even though
the subjects have been exercising regularly for several
years. There was also no statistical diﬀerence in the
amount of physical activity practiced in the two groups.
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Figure 2: Flow-mediated dilation in normal weight and overweight and obese elderly subjects. ∗Statistical diﬀerence between groups,
p < 0 005.
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In support of our results, Lind et al. [5] demonstrated that
the increased level of self-reported physical activity does
not fully eliminate the deleterious cardiovascular conse-
quences associated with overweight and obesity. One
reason supporting our ﬁndings may reside directly in the
physiology of adipose tissue.
Indeed, adipose tissue acts as an endocrine organ that
releases bioactive molecules known as adipokines, overex-
pressed in obese individuals, leading to a proinﬂammatory
status. Among adipose tissue depots, the perivascular adi-
pose tissue (PVAT) displays a unique physiological role
that is a paracrine regulation of vascular function. At the
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Figure 3: Proinﬂammatory markers in normal weight and overweight and obese elderly subjects. C-reactive protein (CRP, a); interleukin-6
(IL-6, b); tumor necrosis factor-α (TNF-α, c); and monocyte chemoattractant protein-1 (MCP-1, d). ∗Statistical diﬀerence between groups,
p < 0 005.
Table 2: Pearson’s correlation between vascular function and inﬂammatory proﬁle in normal weight and overweight and obese groups.
CRP IL-10 IL-1ra IL-1B IL-6 IL-8 MCP-1 TNF-α
Normal weight
FMD% 0.216 0.372 0.608 0.225 0.974 0.397 0.980 0.402
Shear rate 0.252 0.820 0.867 0.178 0.295 0.458 0.962 0.534
FMD/shear rate 0.679 0.748 0.492 0.651 0.325 0.748 0.385 0.620
Overweight & obese
FMD% 0.237 0.800 0.430 0.383 0.248 0.177 0.121 0.709
Shear rate 0.469 0.718 0.640 0.300 0.666 0.799 0.438 0.297
FMD/shear rate 0.670 0.729 0.755 0.616 0.540 0.464 0.582 0.722
Note: CRP, C-reactive protein (ng/mL); IL, interleukin (ng/mL); MCP-1, monocyte chemoattractant protein-1 (ng/mL); TNF-α, tumor necrosis factor-α (ng/
mL). No statistical correlation between variables in both groups were found.
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physiological level, PVAT exerts regulatory eﬀects on
metabolism and inﬂammatory response via the local
release of hormones, cytokines, and reactive oxygen and
nitrogen species. When PVAT exceeds the physiological
level, it carries an anticontractile property that inﬂuences
arteriolar responses to agonists contributing to the regula-
tion of blood ﬂow, nutrient uptake, and tissue homeosta-
sis. Moreover, PVAT is susceptible to inﬂammation and
in obesity inﬁltration of immune cells into the PVAT is
aggravated and the amount of PVAT alongside large and
small vessels is augmented, exerting anticontractile eﬀects
on conduit and resistance arteries [23]. Consequently, an
excess of PVAT might contribute to explain how impaired
adipose tissue homeostasis aﬀects vascular functions in
obese elderly individuals.
4.2. Evidence about the Eﬃcacy of Exercise on Inﬂammatory
Proﬁle in Age-Related Obesity. Recent literature started to
focus on long-term physical activity and inﬂammatory
biomarkers in obese subjects, but results are still contrasting.
Christiansen et al. [16] aimed to investigate the eﬀect of
exercise training and diet-induced weight loss alone or in
combination with inﬂammatory biomarkers. By combining
the weight loss in all three groups, the authors found a
correlation between the degree of weight loss and improve-
ment in several of the inﬂammatory markers. The authors
concluded that the rather large weight losses (<5–7%) were
found to have beneﬁcial eﬀects on circulating inﬂammatory
markers in obese subjects. Furthermore, aerobic exercise for
12 weeks was found to have no eﬀects on circulating inﬂam-
matory markers in these subjects, suggesting that a more
intensive exercise may be necessary to aﬀect systemic
inﬂammation in obese subjects [16]. Brunn et al. [17] aimed
to investigate the eﬀect of a 15-week lifestyle intervention
(hypocaloric diet and daily exercise) on inﬂammatory
biomarkers in severely obese subjects. The intervention
reduced body weight and increased insulin sensitivity. It also
increased plasma adiponectin, while it decreased CRP, IL-6,
IL-8, and MCP-1 levels. In agreement with the previous
study, the authors concluded that the combination of
hypocaloric diet and moderate physical activity resulted in
a signiﬁcant general decrease in the level of inﬂammation
[17]. Pischon et al. [24] investigated the relationship
between physical activity and the obesity-related inﬂamma-
tory markers CRP, IL-6, and soluble TNF-receptors (sTNF-
Rs) 1 and 2. The authors even examined the relationship
between physical activity and insulin sensitivity and whether
inﬂammatory markers mediate this association. In the study,
405 healthy men and 454 healthy women were included and
information about physical activity and other variables were
assessed by questionnaires. Results showed that physical
activity was inversely associated with the plasma levels of
sTNF-R1 and 2, IL-6, and CRP, but after having adjusted
for BMI and leptin (as a surrogate of fat mass), most of these
association were no longer signiﬁcant [24]. Our results are
partially in accordance with the mentioned studies. First,
even though obese individuals without a caloric restriction
diet included in the study are considered very active, no
exercise-induced adaptation on the inﬂammatory proﬁle is
seen. As previously mentioned, although our subjects have
been active already for several years and there is no diﬀer-
ence in the amount of physical activity between groups, they
did not experience great weight changes in the last 5 years,
limiting the eﬀects of the regular physical activity they prac-
tice. In obesity, an increased fat mass is accompanied by
alterations in the cellular composition and physiology of adi-
pose tissue. Hypertrophy and increased distribution of adi-
pocytes, together with inﬂammation and dysregulated
adipokine secretion, characterize a dysfunctional adipose
organ which contributed to the development of several
obesity-associated morbidities [23]. Furthermore, in obesity
the interplay between adipocytes and immune system com-
ponents changes. Immune cells secrete cytokines that
enhance adipose tissue inﬂammation, and at the same time,
adipocytes express classical macrophage features. As the adi-
pose tissue expands, the populations of macrophages, mast
cells, B cells, and T cells increase considerably. As a conse-
quence, there is an increased secretion of the inﬂammatory
adipokines TNF-α and CRP and a reduction of anti-
inﬂammatory adipokines [23]. In turn, proinﬂammatory
adipokines and CRP might express their action on endo-
thelial cells compromising their proliferative rate and
angiogenic potential, which may contribute to the decline
of vascular health and development of symptoms such as
hypertension [25]. Although exercise can be considered
an anti-inﬂammatory treatment as seen in many studies,
it appears that if exercise is not accompanied by an impor-
tant caloric restriction with consequent weight loss, the
eﬀect of exercise on the inﬂammatory proﬁle is poor.
Indeed, only when exercise decreases body fat and adipo-
cyte hypertrophy will the number of inﬂammatory cells
contained within the adipose tissue decline [23]. This
could explain the results found in the individuals included
in our study. While they are very active, accumulating
about 250min of physical activity a week, this does not
seem to be enough to counteract the harmful eﬀect of
age-related adiposity on the inﬂammatory proﬁle of over-
weight and obese elderly people [24, 26].
4.3. Limitations.Although the results of our study are consis-
tent, some limitations have to be highlighted. First, we did
not have any additional control group such as a sedentary
NW group and a sedentary OW&OB group. These two
control groups would have allowed a better understanding
of the exercise-induced adaptation in elderly obese individ-
uals who habitually exercise. Second, we did not investi-
gate any diﬀerence between the subgroups of overweight
and obese who could exhibit diﬀerent responses. Third,
we did not measure any other parameter which could have
helped in the description of the subjects and in the inter-
pretation of the results such as lipid proﬁle, hematocrit,
and white blood cell analysis.
5. Conclusion
Our hypothesis was that regular exercise would not have
helped in maintaining a good inﬂammatory proﬁle and vas-
cular function in overweight and obese elderly individuals.
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We also hypothesized that poorer vascular function would
have been related to higher proinﬂammatory markers in this
population. Although signiﬁcant diﬀerences were found for
the measured variables between overweight and obese sub-
jects compared with nonobese elderly individuals, the results
of our study demonstrated that regular, supervised exercise
without a caloric restriction diet is not a fully successful
stimulus able to counteract the deleterious eﬀect of age-
related adiposity on vascular function and inﬂammatory
proﬁle. Moreover, contrary to our second hypothesis inﬂam-
mation and vascular function do not seem to be correlated
and further studies are needed in order to understand the
mechanisms underlying the exercise-induced physiological
processes that may ensure protection against aging and obe-
sity eﬀects, and studies should be focused on an eﬃcient
exercise program able to trigger positive physiological mech-
anisms against age-induced obesity-related morbidities.
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